Global Pen Needles Market was valued at USD 1.21 Billion in 2021, and it is expected to reach a value of USD 2.57 Billion by 2028, at a CAGR of 11.5% over the forecast period (2022–2028).

Westford, USA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- As the prevalence of diabetes continues to rise, so does the demand for pen needles market. In fact, it is the key factor driving this growth is the increasing number of people with diabetes who are using insulin pens as opposed to syringes and vials. Insulin pens are more convenient and easier to use than syringes and vials, which makes them a preferred choice for many people with diabetes.

There are a variety of different types of pen needles available on the market, and demand for each type depend on consumer’s personal preferences. As per SkyQuest, most of the end-users prefer the type of pen needle they are more comfortable for them works well with their insulin pen.  Some people in the global pen needles market prefer disposable pen needles while others prefer reusable ones. Our findings suggest that disposable pen needles are convenient because consumer can simply throw them away after each use. However, we can see a slight inclination of the market towards reusable pen needles as they can be more cost-effective in the long run, but they require more care and cleaning between uses.

As the demand for insulin grows, so does the demand for pen needles. Pen needles are a vital part of any diabetes treatment plan, and with the rising prevalence of diabetes, the market for pen needles is growing exponentially.

There are a few factors driving pen needles market growth. First, as mentioned, the prevalence of diabetes is on the rise. According to the World Health Organization, there were an estimated 422 million adults living with diabetes in 2020, and this number is expected to rise to 642 million by 2040. With such a large and growing population of diabetics, the need for pen needles is also increasing.

Second, advances in technology have led to the development of new types of pen needles that are thinner, sharper, and more comfortable to use. These newer generations of pen needles make it easier and less painful for patients to inject insulin, which leads to better compliance with treatment plans.

Get sample copy of this report:

https://skyquestt.com/sample-request/pen-needles-market

Lastly, an increase in insurance coverage for diabetes supplies has made it more affordable for patients in the global pen needles market to purchase pen needles and other necessary supplies. In the past, many patients could not afford to purchase these items out-of-pocket, but now that insurance companies are beginning to cover more of the costs associated with diabetes care.

Safety Pen Needles Generates Only 15% Market Revenue

As the prevalence of diabetes continues to grow around the world, so does the demand for safety pen needles. These special pens are designed to safely and effectively inject insulin into the body, and they are becoming increasingly popular among diabetics of all ages.

There are a number of reasons why safety pen needles are in such high demand. For one, they help to minimize the risk of accidentally sticking oneself with a used needle. They also provide a more comfortable injection experience, as the needles are much thinner than those used in traditional syringes. However, only 15% of the pen needles market revenue comes from this segment as limited number of people with diabetes prefer safety pen needles because they offer a higher level of precision when injecting insulin. This is important for maintaining proper blood sugar levels and avoiding potentially dangerous complications.

On the other hand, a new study from SkyQuest shows that standard pen needles are responsible for generating 85% of the global pen needles market revenue for insulin delivery devices. This is a significant finding, as it means that the vast majority of people who use insulin pens are still using the traditional needle-and-syringe method, rather than more advanced methods such as pre-filled pens or cartridge-based systems.

There are a number of reasons why standard pen needles are so popular, including their low cost and easy availability. However, it is worth noting that they are also associated with a number of disadvantages, such as a higher risk of infection and greater pain during injection.

Browse summary of the report and Complete Table of Contents (ToC):

https://skyquestt.com/report/pen-needles-market

Key Innovations in Pen Needles Market

The pen needles industry is constantly innovating to provide patients with the best possible experience. The latest innovation in this field is the use of smart technology to create a more user-friendly experience. Smart pen needles are able to connect to a smartphone or tablet and provide real-time feedback on things like insulin levels and delivery rates. This can be a huge help for consumers in the global pen needles market who have to manage their diabetes carefully. It also means that people with diabetes can have more control over their condition and treatment.

The other big innovation in pen needles is the development of nanotechnology. This has led to the creation of needles that are much thinner and sharper than before. This makes them much more comfortable to use and helps to reduce the risk of injections becoming painful or causing bruising. overall, the latest innovations in pen needles are making life easier for people with diabetes and helping to improve the quality of care they receive.

Another recent innovation in pen needles market is the development of new coatings that can make the needles even smoother and less likely to cause pain or irritation. Some of the most popular new coatings include silicone and Teflon. These coatings help to reduce friction and make it easier for the needle to glide through the skin.

The latest generation of pen needles is also being manufactured using more advanced methods that improve their quality and safety. For example, many manufacturers are now using laser cutting technology to create a more precise and consistent needle tip.

Rapid Expansion of Needless Pen May Challenge Growth of Pen Needles Market Momentum

Global pen needles market is anticipated to grow at a CAGR of over 11.5% during the forecast period of 2022-2028. The primary factor driving this market is the increasing prevalence of diabetes and the growing number of insulin users worldwide.

On the other hand, the market is slowly witnessing rising demand for needle-free injection devices and the availability of advanced delivery systems are expected to disturb the market growth in the years to come.

However, the rapid expansion of needleless pens may challenge the momentum of the pen needles market in the coming years. Needleless pens are easy to use and offer a pain-free injection experience, which is likely to result in higher patient preference. Additionally, several key players are investing in the development of needleless pen technologies, which is expected to further intensify competition in the market. Currently, the technology is still under development and very small number of players are manufacturing them. In addition, most of the patients find them very expensive to buy as compared to other pen needles. However, our research suggests that the by 2030, the market is likely to witness a significant improvement in the needle-less pen manufacturing technology and decline in the cost. As a result, the pen needles market may start witnessing a blow on the growth trajectory.

Speak to Analyst for your custom requirements:

https://skyquestt.com/speak-with-analyst/pen-needles-market

Top Players in Global Pen Needles Market

Novo Nordisk A/S (Denmark)

Becton, Dickinson, and Company (US)

B. Braun Melsungen AG (Germany)

Artsana S.p.A. (Italy)

ECR Pharmaceuticals Co., Ltd. (US)

CR Pharmaceuticals Co., Ltd. (China)

Related Reports in SkyQuest’s Library:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Fresh blood was found on patient’s gown

Prisoner advocacy group calls observation level at Ash Street Jail inadequate; says suicidal suspect Adam Howe should have been sent to Bridgewater.

The subvariant has been slowly increasing in prevalence across the U.S., even as the BA.5 subvariant of Omicron remains the dominant strain with 79.2% of the cases. The BA.4.6 subvariant has been found to be better at evading COVID-19 antibody therapies, with the U.S. Food and Drug Administration in early October warning healthcare providers that AstraZeneca's Evusheld had the risk of being ineffective against some variants it cannot neutralize.

Health officials say the strain is worrisome because it may evade prior protections and not respond to current vaccines.

Exhausted nurses and staff triage an often-packed emergency room lobby at all hours, five days in to an outage of the hospital's records system.

Medicare’s annual open enrollment period begins on Oct. 15 and ends on Dec. 7. More than seven in 10 Medicare beneficiaries did not even compare plans during this period in 2018, according to the Kaiser Family Foundation, a nonprofit group focused on health policy. Many times, it’s because making the change — or just reviewing the options — can be overwhelming, said Dave Francis, chief executive officer and co-founder of Healthpilot, a company whose services include automated and personalized Medicare plan recommendations.

One of the great things about investing in stocks is that you don't need millions of dollars in the bank to get started. Let's look at an incredible healthcare stock whose shares are changing hands for just about $44 (as of this writing): Pfizer (NYSE: PFE). Pfizer is a major pharmaceutical company with a rich lineup of medicines and vaccines.

Parkinson's disease affects around one million people in the United States, according to the Parkinson's Foundation. Beyond that, the number of people who are diagnosed with the disease in the U.S. each year is in the range of 60,000. In fact, following Alzheimer's, it's the most common neurodegenerative disease.A condition that affects a person's nervous system, the exact cause of Parkinson's isn't clear. However, there are things that you can do to try to prevent it. And according to findings

Contrary to popular belief, the simple approach to many things in life is often the most effective. An investing quote from Motley Fool contributor Brian Feroldi that I believe is highly underrated goes as follows: "Good investing is 99% patience and 1% action." The pharmaceutical giant Amgen (NASDAQ: AMGN) and medical devices maker Stryker (NYSE: SYK) are two healthcare stocks that appear poised to create wealth for shareholders who are patient and measured enough to let them.

Bank of America analysts on Friday told investors that Eli Lilly & Co. Inc.’s (LLY) diabetes treatment and possible weight-management drug could be a $100 billion medication. The drug, tirzepatide, received Food and Drug Administration approval as a treatment for Type 2 diabetes earlier this year. It has also shown in clinical trials that it can help people lose up to 20% of their body weight.

The cuts are intended to reduce costs, streamline operations and increase profitability for BioMarin, frequently tapped as a likely takeover target.

If you want to burn fat, should you do cardio or lift weights? Experts weigh in on the benefits of cardio and strength training for weight loss.

A large number of U.S. COVID deaths could be prevented if patients would take Paxlovid, the antiviral developed by Pfizer that helps reduce the risk of hospitalization and death, according to White House COVID coordinator Dr. Ashish Jha.

President Joe Biden has said the pandemic is over, despite more than 300 people dying from COVID-related illness every day. Now cruise lines, which experienced severe disruptions during the early days of the COVID-19 outbreak and, in some cases were stranded offshore due to ports refusing them permission to dock due to coronavirus outbreaks onboard, are relaxing their health protocols. Harry Sommer, chief executive of Norwegian Cruise Line  cited “significant, positive progress in the public-health environment.”

The health system Kaiser Permanente called doctors in during lunch and after work and urged them to add additional illnesses to the medical records of patients they hadn’t seen in weeks. Doctors who found enough new diagnoses could earn bottles of Champagne or a bonus in their paycheck. Anthem, a large insurer now called Elevance Health, paid more to doctors who said their patients were sicker. And executives at UnitedHealth Group, the country’s largest insurer, told their workers to mine old me

Medicare's annual open enrollment period is just around the corner. Between Oct. 15 and Dec. 7, seniors can make changes to their plans for 2023. But before you dive into the new options, it's helpful to know about some big changes the government has made to the program for next year.

When it comes to weight loss, it’s good to come up with a strategy and think about what workouts will help you burn those extra calories. Cardio is an excellent exercise to incorporate into your fitness routine not only to lose weight but to promote heart health, lower blood pressure and boost ...

The White House held the Conference on Hunger, Nutrition, and Health -- the first such conference in 50 years -- on Sept. 28 to address hunger and diet-related diseases. The event comes amid a U.S....

(Bloomberg) -- CVS Health Corp. is in exclusive talks to buy Cano Health Inc., the health-care provider backed by billionaire Barry Sternlicht, according to people familiar with the matter. Most Read from BloombergBiden Says Putin Threats Real, Could Spark Nuclear ‘Armageddon’Biden Should Hit Saudi Arabia Where It Really HurtsNATO Once Feared a Putin Victory. Now It Worries Over His DefeatFacebook Is Warning 1 Million Users About Stolen Usernames, PasswordsStock Traders Hit Sell Button on Hawkis

"This is something that affects our whole livelihood," the 'I Am Jazz' star says of top surgery.